Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent to Make Pfizer's Advil Liqui-Gels Minis | Contract Pharma

What are you searching for?

Sign in
Breaking News

Catalent to Make Pfizer’s Advil Liqui-Gels Minis

Next-gen OTC pain relief product will feature OptiGel Mini technology

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

After a 20-year collaboration on the development and manufacture of Advil Liqui-Gels (ibuprofen), Catalent Pharma Solutions it has entered into an exclusive long-term supply agreement to produce the next generation of Pfizer’s leading over-the-counter (OTC) pain relief product with the launch of new Advil Liqui-Gels Minis, using Catalent’s softgel platform OptiGel Mini technology.

The product delivers pain relief in a more concentrated fill resulting in a smaller, more convenient capsule. Smaller capsules are easier to swallow for consumers who may have difficulty swallowing, especially for the pediatric and geriatric markets.

Advil is one of the world’s leading brands of ibuprofen pain relievers and its Liqui-Gels franchise is one of the most successful dose forms in the analgesics market.

“Catalent is proud to collaborate with Pfizer to develop Advil Liqui-Gels Minis and to bring this even more convenient and consumer-friendly dose form to market,” said Aris Gennadios, president of softgel technologies, Catalent.

Catalent’s St. Petersburg, FL, facility has already formulated and is manufacturing the new format for Pfizer, with the new product recently launched in the U.S. market.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics